Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
29,328,179
-
Total 13F shares
-
22,716,898
-
Share change
-
+811,527
-
Total reported value
-
$311,677,195
-
Put/Call ratio
-
244%
-
Price per share
-
$13.72
-
Number of holders
-
126
-
Value change
-
-$4,364,825
-
Number of buys
-
83
-
Number of sells
-
59
Institutional Holders of Castle Biosciences Inc - Common Stock (CSTL) as of Q2 2023
As of 30 Jun 2023,
Castle Biosciences Inc - Common Stock (CSTL) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,716,898 shares.
The largest 10 holders included
WASATCH ADVISORS LP, Granahan Investment Management, LLC, BlackRock Inc., VANGUARD GROUP INC, PRINCIPAL FINANCIAL GROUP INC, Bellevue Group AG, MILLENNIUM MANAGEMENT LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, PALISADE CAPITAL MANAGEMENT, LP, and STATE STREET CORP.
This page lists
127
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.